LATERAL FLOW ASSAY MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Rising awareness and funding for disease screening and surveillance programs

Rising awareness about the importance of disease screening and surveillance globally can drive the market growth. Both developing and developed countries focuses on implementation of national screening programs for priority health issues to achieve early detection and treatment. This boosts demand for point-of-care testing devices. Moreover, there has been increase in government and private sector funding for infectious disease control, maternal and child healthcare programs. All these screening initiatives rely heavily on rapid, portable assays to decentralize testing and reach remote populations. Lateral flow assays are used in large surveillance programs due to their applicability in resource-limited field conditions and ability to provide timely results. These assays have been widely used in HIV, malaria and tuberculosis prevalence studies across Africa and Asia. Their usage grows further with more funding directed at expanding testing and vaccination coverage for communicable and non-communicable diseases. The portability and ease of use of lateral flow assays makes them a preferred technology for field healthcare camps, refugee camps and other temporary testing sites.